Barclays Upgrades Alexion Pharmaceuticals (ALXN) to Overweight

November 29, 2016 6:42 AM EST Send to a Friend
(Updated - November 29, 2016 8:15 AM EST)Barclays upgraded Alexion Pharmaceuticals (NASDAQ: ALXN) from Equalweight to Overweight with a price ...

To continue reading this article and more like it please sign-in or join today (FREE!)

Member Login